|
A U.S. initiative to compare the merits of competing medical treatments will consume $1.1 billion of the funds provided by the economic stimulus act. Comparative effectiveness is viewed as a viable way to help drive down spiraling health care costs while continuing to provide quality care. Proponents maintain this direction will prioritize research for surgical procedures and medical devices. Some are concerned that individuals' unique medical needs might not be considered, or that regulatory burdens will quash medical innovation. What's your view of this policy? Can 'one-size' fit all?
The preceding article is a "sneak peek" from Medical Equipment Design, a newsletter from GlobalSpec. To stay up-to-date and informed on industry trends, products, and technologies, subscribe to Medical Equipment Design today.
|